Publication | Closed Access

Wharton’s Jelly-derived mesenchymal stem cells alleviate memory deficits and reduce amyloid-β deposition in an APP/PS1 transgenic mouse model

Neurodegenerative DiseasesAlzheimer's DiseaseMedicineStem Cell EngineeringWharton ’Amyloid-β DepositionStem Cell ResearchStem-cell TherapyNeuroscienceStem Cell TherapiesMesenchymal Stem CellStem Cell BiologyStem CellsCell Biology